DUEXIS

This brand name is authorized in United States.

Active ingredients

The drug DUEXIS contains a combination of these active pharmaceutical ingredients (APIs):

`1`	Ibuprofen UNII `WK2XYI10QM` - IBUPROFEN
	Ibuprofen is a propionic acid derivative NSAID that has demonstrated its efficacy by inhibition of prostaglandin synthesis. In humans ibuprofen reduces inflammatory pain, swellings and fever. Furthermore, ibuprofen reversibly inhibits platelet aggregation.
	Read more about Ibuprofen
`2`	Famotidine UNII `5QZO15J2Z8` - FAMOTIDINE
	Famotidine is a potent competitive H₂-receptor antagonist. Famotidine has a rapid onset of action and, at the recommended doses, has a long duration of action and is highly effective at relatively low blood concentrations.
	Read more about Famotidine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
DUEXIS Coated tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
US	FDA, National Drug Code	75987-010

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.